Axon Enterprise, Inc $AXON Shares Bought by Oppenheimer Asset Management Inc.

Posted by Stanley Muller on Aug 15th, 2026

Oppenheimer Asset Management Inc. grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 72.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,554 shares of the biotechnology company’s stock after buying an additional 9,447 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Axon Enterprise were worth $12,644,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in AXON. Edgewood Management LLC bought a new position in Axon Enterprise during the 4th quarter valued at $846,516,000. Wellington Management Group LLP increased its position in shares of Axon Enterprise by 326.9% in the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock worth $874,463,000 after purchasing an additional 1,179,038 shares during the last quarter. Norges Bank acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at about $515,764,000. Styrax Capital LP acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at about $84,938,000. Finally, Sands Capital Management LLC lifted its position in shares of Axon Enterprise by 11.6% during the fourth quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock worth $914,047,000 after purchasing an additional 167,095 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 0.4%

NASDAQ AXON opened at $612.83 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $794.29. The company has a 50-day simple moving average of $526.06 and a 200-day simple moving average of $474.40. The firm has a market capitalization of $49.78 billion, a PE ratio of 254.29, a price-to-earnings-growth ratio of 12.56 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the prior year, the business earned $2.12 earnings per share. Axon Enterprise’s quarterly revenue was up 35.3% on a year-over-year basis. On average, equities analysts forecast that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on AXON shares. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. UBS Group upped their price objective on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a report on Thursday, August 6th. The Goldman Sachs Group reiterated a “buy” rating and issued a $715.00 target price on shares of Axon Enterprise in a research report on Thursday, August 6th. Finally, JPMorgan Chase & Co. boosted their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $730.92.

Get Our Latest Research Report on AXON

Insider Activity at Axon Enterprise

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the sale, the insider owned 52,813 shares in the company, valued at $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is owned by insiders.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Axon raised its full-year 2026 revenue-growth outlook to 32%–34%, supported by approximately $15.1 billion in future contracted bookings and strong momentum in connected devices, AI-enabled software and counter-drone offerings. Second-quarter revenue increased 35.3% year over year to $904.4 million and exceeded analyst expectations. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53. The firm also increased estimates for Q1, Q2, Q3 and Q4 2027, suggesting stronger expected earnings momentum beyond 2026.
Positive Sentiment: The company’s second-quarter adjusted earnings and revenue surpassed Wall Street expectations, while management highlighted broad demand for Axon’s public-safety technology ecosystem. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
Neutral Sentiment: Northland reduced its FY2026 EPS estimate to $3.12 from $3.26 and lowered its Q4 2026 forecast to $1.29 from $1.55, partly offsetting the more optimistic 2027 outlook.
Negative Sentiment: Despite strong sales, quarterly net income fell to $29.4 million from $36.1 million a year earlier, and diluted EPS declined to $0.36 from $0.44. Investors remain concerned about margins, elevated costs, debt and Axon’s very high valuation. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
Negative Sentiment: Recent insider selling has added pressure and increased investor caution around the stock’s valuation. Axon Enterprise Trading Down Following Insider Selling

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.